Chazan, Grace and Jupp, Jennifer and Bauters, Tiene and Duncan, Nick and Weddle, Kellie Jones and Nomura, Hisanaga and O'Connor, Shaun and Chan, Alexandre and Alkhudair, Nora and Alsamrani, Majed and Buie, Larry W. and Chambers, Pinkie and Chieh, Tan Wen and DeRemer, David L. and Duvivier, France and Katabalo, Deoogratias and McFarlane, Thomas and Mckavanagh, Daniel and Mensah, Kfi and Moreno Martinez, Estela and Rowan, Gail and Sae-teaw, Manit and Tadesse, Tamrat Assefa and Weru, Irene and Alexander, Marliese (2022) Impact of coronavirus of 2019 on the delivery of pharmacy services to patients with cancer: An international survey of oncology pharmacy practitioners. Journal Of Oncology Pharmacy Practice, 28 (8). pp. 1832-1847. ISSN 1078-1552, DOI https://doi.org/10.1177/10781552211048892.
Full text not available from this repository.Abstract
Introduction The coronavirus of 2019 pandemic has necessitated vast and rapid changes in the way oncology pharmacy services are delivered around the world. Methods/aims An international survey of oncology pharmacists and technicians was conducted via the International Society of Oncology Pharmacy Practitioners and collaborating global pharmacy organisations to determine the impact that the coronavirus of 2019 has had on pharmacy service delivery, pharmacy practitioners and oncology practice. Results The survey received 862 responses from 40 different countries from September to October 2020. The majority of respondents were pharmacists (n = 841, 97.6%), with 24% involved in the direct care of patients with the coronavirus of 2019. Of the survey participants, 55% increased their time working remotely, with remote activities including dispensing, patient assessment/follow-up and attending multi-disciplinary rounds. Respondents reported a 72% increase in the use of technology to perform remote patient interaction activities and that participation in educational meetings and quality improvement projects was reduced by 68% and 44%, respectively. Workforce impacts included altered working hours (50%), cancelled leave (48%) and forced leave/furloughing (30%). During the pandemic, respondents reported reduced access to intensive care (19%) and anti-cancer (15%) medications. In addition, 39% of respondents reported reduced access to personal protective equipment, including N95 masks for chemotherapy compounding. Almost half of respondents (49%) reported that cancer treatments were delayed or intervals were altered for patients being treated with curative intent. A third of practitioners (30%) believed that patient outcomes would be adversely impacted by changes to pharmacy services. Sixty-five percent of respondents reported impacts on their mental health, with 12% utilising support services. Conclusion The coronavirus of 2019 pandemic has altered the way oncology pharmacy services are delivered. These results demonstrate the adaptability of the oncology pharmacy profession and highlight the importance of formal evaluation of the varied practice models to determine the evidence-based practices that enhance pharmacy services and, thus, should be reinstated as soon as practical and reasonable.
| Item Type: | Article |
|---|---|
| Funders: | UNSPECIFIED |
| Uncontrolled Keywords: | Coronavirus; Coronavirus Infections; Humans; Medical Oncology; Neoplasms; Pharmaceutical services; Pharmacists; Pharmacy; Surveys and questionnaires |
| Subjects: | R Medicine > RS Pharmacy and materia medica |
| Divisions: | Universiti Malaya Medical Centre (UMMC) |
| Depositing User: | Ms. Juhaida Abd Rahim |
| Date Deposited: | 05 Aug 2025 07:47 |
| Last Modified: | 05 Aug 2025 07:47 |
| URI: | http://eprints.um.edu.my/id/eprint/41026 |
Actions (login required)
 |
View Item |
